Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism. | Int J Mol Sci | 2023 | 37176148 | PubTator, text mining | PubMed |
| Special Issue "Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0". | Int J Mol Sci | 2023 | 37175624 | PubTator, text mining | PubMed |
| An Evaluation of the Cytotoxic and Genotoxic Effects of the Marine Toxin C17-SAMT in Human TK6 and HepaRG Cell Lines. | Int J Mol Sci | 2023 | 37175512 | PubTator, text mining | PubMed |
| A positive feedback loop between ID3 and PPARγ via DNA damage repair regulates the efficacy of radiotherapy for rectal cancer. | BMC Cancer | 2023 | 37170184 | PubTator, text mining | PubMed |
| Mitotic clustering of pulverized chromosomes from micronuclei. | Nature | 2023 | 37165191 | PubTator, text mining | PubMed |
| Radiotherapy and radio-sensitization in H3K27M -mutated diffuse midline gliomas. | CNS Neurosci Ther | 2023 | 37157237 | PubTator, text mining | PubMed |
| Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer. | NPJ Breast Cancer | 2023 | 37156759 | PubTator, text mining | PubMed |
| RNF8 depletion attenuates hepatocellular carcinoma progression by inhibiting epithelial-mesenchymal transition and enhancing drug sensitivity. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37154586 | PubTator, text mining | PubMed |
| Deficient Radiation Transcription Response in COVID-19 Patients. | Adv Radiat Oncol | 2023 | 37152486 | PubTator, text mining | PubMed |
| A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy. | Bioact Mater | 2023 | 37122898 | PubTator, text mining | PubMed |
| Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation. | Int J Mol Sci | 2023 | 37108815 | PubTator, text mining | PubMed |
| R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance. | Int J Mol Sci | 2023 | 37108225 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score. | Crit Care | 2023 | 37085849 | PubTator, text mining | PubMed |
| Ubiquitin E3 ligases in cancer: somatic mutation and amplification. | BMB Rep | 2023 | 37081755 | PubTator, text mining | PubMed |
| De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity. | Oncogene | 2023 | 37081042 | PubTator, text mining | PubMed |
| WHSC1 is involved in DNA damage, cellular senescence and immune response in hepatocellular carcinoma progression. | J Cell Mol Med | 2023 | 37073435 | PubTator, text mining | PubMed |
| Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients. | Med Oncol | 2023 | 37060468 | PubTator, text mining | PubMed |
| Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. | Transl Neurodegener | 2023 | 37055865 | PubTator, text mining | PubMed |
| NUSAP1 Binds ILF2 to Modulate R-Loop Accumulation and DNA Damage in Prostate Cancer. | Int J Mol Sci | 2023 | 37047232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=11